Europe Continuous Glucose Monitoring Market Growth Forecast and Consumer Insights

Key Insights

The European Continuous Glucose Monitoring (CGM) market is experiencing robust growth, projected to reach €2.04 billion in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 11.33% from 2025 to 2033. This expansion is driven by several key factors. The increasing prevalence of diabetes, particularly type 1 and type 2, across major European countries like Germany, France, and the UK, fuels demand for advanced glucose monitoring solutions. Technological advancements leading to smaller, more accurate, and user-friendly CGM devices are also significantly impacting market growth. Furthermore, rising healthcare expenditure and increasing awareness among patients about the benefits of CGM for better diabetes management contribute to market expansion. The segment encompassing CGM sensors is expected to dominate the market due to the recurring nature of sensor replacements, creating a consistent revenue stream.

The market's growth is not without challenges. High initial costs associated with CGM systems and the lack of reimbursement coverage in certain regions remain significant restraints. However, ongoing technological innovations are addressing these challenges, with companies continuously striving for cost-effective solutions. Future growth will likely be shaped by the increasing adoption of integrated CGM systems that seamlessly connect with insulin pumps and other diabetes management tools. The competitive landscape is marked by key players like Medtronic, Abbott, Dexcom, Senseonics, and Ascensia, engaged in continuous product development and strategic partnerships to expand market reach. The European market offers substantial growth potential, especially in countries with burgeoning diabetic populations and supportive healthcare infrastructures. Further market segmentation will likely emerge based on specific CGM features such as real-time data transmission capabilities, integration with mobile applications, and variations in sensor lifespan.

Europe Continuous Glucose Monitoring Market: A Comprehensive Report (2019-2033)

This comprehensive report provides an in-depth analysis of the Europe Continuous Glucose Monitoring (CGM) market, offering invaluable insights for stakeholders across the industry. From market dynamics and leading players to emerging opportunities and future trends, this report covers all key aspects of this rapidly evolving sector. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this analysis provides a robust understanding of the historical, current, and future state of the European CGM market. The report is meticulously structured to deliver actionable intelligence, supported by data and analysis, enabling informed decision-making. The market size in 2025 is estimated at xx Million.

Europe Continuous Glucose Monitoring Market Market Dynamics & Concentration

The European CGM market is characterized by a dynamic interplay of factors influencing its growth and concentration. Market concentration is moderately high, with key players like Medtronic, Abbott, and Dexcom holding significant market share. However, the presence of smaller players like Senseonics and Ascensia, and the emergence of new entrants, ensures a competitive landscape. The market share of "Other Company Share Analyse" is estimated at xx% in 2025. Innovation is a key driver, with continuous advancements in sensor technology, data analytics, and integration with mobile devices fueling market expansion. Stringent regulatory frameworks, primarily governed by the European Medicines Agency (EMA), ensure product safety and efficacy. While minimally invasive procedures such as blood glucose finger-prick tests remain substitutes, the convenience and continuous data provided by CGMs are driving market preference. End-user trends are shifting towards personalized diabetes management, demanding advanced features such as remote monitoring and integrated insulin delivery systems. M&A activities in the sector have been moderate, with xx deals recorded between 2019 and 2024, largely driven by companies aiming to expand their product portfolios and geographical reach.

• Market Concentration: Moderately high, with top 3 players holding xx% market share (2025).
• Innovation Drivers: Improved sensor accuracy, smaller device size, enhanced data analytics, and mobile app integration.
• Regulatory Framework: Stringent EMA regulations driving product safety and efficacy.
• Product Substitutes: Blood glucose meters (BGMs), but CGM adoption is increasing rapidly due to continuous data and improved convenience.
• End-User Trends: Increasing demand for personalized diabetes management and remote monitoring capabilities.
• M&A Activities: xx deals between 2019 and 2024, primarily for portfolio expansion and market penetration.

Europe Continuous Glucose Monitoring Market Industry Trends & Analysis

The European CGM market exhibits robust growth, driven by several key factors. Rising prevalence of diabetes, particularly type 1 and type 2, is the primary driver. The increasing awareness about the benefits of continuous glucose monitoring, such as improved glycemic control and reduced hypoglycemic events, is further fueling market expansion. Technological advancements, including the development of more accurate, comfortable, and user-friendly devices, are also contributing significantly. Consumer preferences are shifting towards minimally invasive and easily integrated devices with seamless data sharing capabilities. The competitive landscape is marked by intense rivalry among established players, along with the entry of new players and technological innovations, which further contributes to the market's dynamic nature. The market is expected to exhibit a CAGR of xx% during the forecast period (2025-2033), with market penetration expected to reach xx% by 2033.

Leading Markets & Segments in Europe Continuous Glucose Monitoring Market

Germany, the UK, and France represent the leading markets within Europe for CGMs, driven by high diabetes prevalence, robust healthcare infrastructure, and greater adoption rates. This dominance is sustained by factors such as favorable reimbursement policies, well-established healthcare systems, and strong technological adoption rates.

• Key Drivers for Leading Markets:
  • Germany: High diabetes prevalence, advanced healthcare infrastructure, strong regulatory support.
  • UK: Well-developed healthcare system, increasing government focus on diabetes management.
  • France: Growing awareness of CGM benefits, robust healthcare infrastructure.

The CGM market is segmented into Sensors and Durables. The Sensors segment holds a larger market share due to the recurring nature of sensor replacements. The Durables segment, encompassing the CGM device itself, represents a significant portion of the overall market value. The continuous need for sensor replacements drives the high growth of the Sensors segment.

Europe Continuous Glucose Monitoring Market Product Developments

Recent product innovations in the European CGM market focus on improving accuracy, extending sensor lifespan, reducing device size, and enhancing user experience. This includes advancements in sensor technology, data analytics algorithms, and integration with mobile applications. These developments improve ease of use and the effectiveness of the data obtained. The aim is to create more user-friendly devices that seamlessly integrate into daily routines and provide accurate, real-time glucose monitoring.

Key Drivers of Europe Continuous Glucose Monitoring Market Growth

Several factors contribute to the growth of the European CGM market. These include the rising prevalence of diabetes, increasing awareness among patients and healthcare professionals regarding the benefits of CGM, technological advancements leading to improved accuracy and usability, and supportive regulatory frameworks facilitating market access. Furthermore, favorable reimbursement policies in several European countries enhance affordability and adoption rates. Improved data analytics capabilities allow for better disease management and personalized treatment.

Challenges in the Europe Continuous Glucose Monitoring Market Market

The market faces challenges such as the high cost of CGM systems, which can limit accessibility for some patients. Supply chain disruptions and the competitive intensity from existing and new players pose additional hurdles. Regulatory hurdles related to reimbursement policies and product approvals can also slow down market growth. These factors can impact the overall market expansion and penetration rates. The high cost could limit affordability and thus slow market penetration. Supply chain disruptions may lead to temporary shortages affecting market stability.

Emerging Opportunities in Europe Continuous Glucose Monitoring Market

Emerging opportunities include the growing adoption of hybrid closed-loop systems, which combine CGM with insulin pumps for automated insulin delivery. The development of integrated diabetes management platforms that encompass CGM data, along with other health metrics, offers significant growth potential. Strategic partnerships between CGM manufacturers and healthcare providers can enhance market access and create new business models.

Leading Players in the Europe Continuous Glucose Monitoring Market Sector

• Medtronic
• Abbott
• Other Company Share Analyse
• Dexcom
• Senseonics
• Ascensia

Key Milestones in Europe Continuous Glucose Monitoring Market Industry

• June 2022: Ascensia Diabetes Care and Senseonics Holdings, Inc. receive CE Mark approval for the Eversense E3 CGM System, expanding market access within the EU.
• October 2023: Medtronic introduces Simplera, a new CGM designed for individuals with diabetes aged 2 and above, currently undergoing FDA evaluation. This launch signals a shift towards younger patient populations and simplified device designs.

Strategic Outlook for Europe Continuous Glucose Monitoring Market Market

The European CGM market holds significant long-term growth potential. Continued technological advancements, increasing diabetes prevalence, and supportive regulatory environments will be key drivers. Strategic partnerships and collaborations among stakeholders, including manufacturers, healthcare providers, and payers, will be crucial in maximizing market penetration and improving patient outcomes. Focusing on user-friendly features and integration with other diabetes management tools will be paramount for continued market success.

Europe Continuous Glucose Monitoring Market Segmentation

• 1. Continuous Glucose Monitoring
  • 1.1. Sensors
  • 1.2. Durables

Europe Continuous Glucose Monitoring Market Segmentation By Geography

• 1. France
• 2. Germany
• 3. Italy
• 4. Spain
• 5. Russia
• 6. United Kingdom
• 7. Rest of Europe